Gapping down:
In reaction to disappointing earnings/guidance: DTLK -16.5% (light volume), UIS -15.7%, CREE -15.6%, USNA -10.3%, IRBT -9.5%, BRCM -7.9%, FTI -7.2%, VOCS -7.2%, (light volume), RFMD -7%, STM -6.4%, ALTR -6.2%, XOOM -5.7%, CBST -4.8%, (light volume), PNRA -4.3%, CAT -3.6%, ZIOP -3.4% (also announces offering of $50 mln of shares of its common stock), HA -2.2% (light volume), RHI -1.8% (light volume), JNPR -1.8%, GSK -0.6%, BPOP -0.5%, (light volume), .
M&A related: MW -0.7% (Men's Wearhouse considering buying Allen Edmonds, according to WSJ.com), .
Select financial related names showing weakness: NBG -3.8%, RBS -3.6% (downgraded to Underperform from Market Perform at Keefe Bruyette), SAN -3%, DB -2.2%, IRE -2.2%, HBC -1.8%, BBVA -1.7%, BAC -1.2%, C -0.7%, RF -0.8% (Regions Financial downgraded to Neutral from Buy at SunTrust) .
Select metals/mining stocks trading lower: RIO -2.8%, MT -1.6%, BBL -1.5%, SLV -0.6%, GLD -0.5%, VALE -0.4%, .
Select telecom related names showing early weakness: ORAN -4%, CHU -4%, TEF -2.8%.
A few solar names are lower: SOL -3.6%, SPWR -2.9%, FSLR -1.5%
Other news: CMFO -65% (announces going dark and voluntary delisting from NYSE), RPRX -49.3% (receives FDA guidance for Androzal clinical program), APPY -11.2% ( files to sell $20 mln of common stock), AMRN -5.3% (plans to reduce expenses by decreasing staff following recent FDA Advisory Committee vote), NFLX -4.5% (Icahn filed 13-D disclosing reduced stake in co following recent stock sales), FB -2.3% (still checking, may be attributed to rule tightening on violent content), SNE -2% (still checking), DE -1.6% / MTW -1.5% (following CAT results), XLNX -1.5% (following BRCM results), CENX -1.4% (following late spike on volume), CCI -1.2% ( prices 36 mln shares of common stock at $74.00 per share; prices 8.5 mln shares of its 4.50% Mandatory Conv Pref Stock at $100.00 per share ), QCOM -0.8% (following BRCM results), SNDK -0.5% ( to offer $1 bln of convertible senior notes).
Analyst comments: ARMH -2.7% (downgraded to Neutral from Buy at UBS), COH -1.4% (downgraded to Neutral from Buy at BofA/Merrill, downgraded at Argus), EXC -1.4% (downgraded to Underperform from Hold at Jefferies), INFI -1.3% (downgraded to Neutral from Buy at UBS), BAX -1.1% (downgraded to Market Perform from Outperform at Cowen)